1h Free Analyst Time
Oncomark Ltd (Oncomark) is a diagnostics company that develops prognostic and predictive assays for the treatment of cancer. The company’s product include OncoMasTR, is a novel prognostic assay used to identify the early stage breast cancer. It has a range of tissue-based biomarker assays under development which are suited to Pharmacodynamic and Patient Stratification studies. Oncomark‘s research projects are primarily taken for breast cancer, prostate cancer, colorectal cancer and melanoma skin cancer. The company work with other organizations through research and development, technology and commercial collaborations to develop novel products. Oncomark is headquartered in Dublin, Ireland.Speak directly to the analyst to clarify any post sales queries you may have.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oncomark Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Oncomark Ltd Company Overview
- Oncomark Ltd Company Snapshot
- Oncomark Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Oncomark Ltd - Pipeline Analysis Overview
- Oncomark Ltd - Key Facts
- Oncomark Ltd - Major Products and Services
- Oncomark Ltd Pipeline Products by Development Stage
- Oncomark Ltd Pipeline Products Overview
- OncoMasTR - Bladder Cancer
- OncoMasTR - Bladder Cancer Product Overview
- OncoMasTR - Breast Cancer
- OncoMasTR - Breast Cancer Product Overview
- OncoMasTR - Colorectal Cancer
- OncoMasTR - Colorectal Cancer Product Overview
- OncoMasTR - Melanoma
- OncoMasTR - Melanoma Product Overview
- OncoMasTR - Multiple Myeloma
- OncoMasTR - Multiple Myeloma Product Overview
- OncoMasTR - Predictive Biomarker Test
- OncoMasTR - Predictive Biomarker Test Product Overview
- OncoMasTR - Prostate Cancer
- OncoMasTR - Prostate Cancer Product Overview
- Oncomark Ltd - Key Competitors
- Oncomark Ltd - Key Employees
- Oncomark Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Oncomark Ltd, Recent Developments
- Feb 15, 2017: OncoMark Secures €2.1 Million Investment to Commercialise New Diagnostic Test for Breast Cancer
- Nov 24, 2010: OncoMark Appoints Dara FitzGerald As CEO
- Appendix
- Methodology
- About
- Contact
- Disclaimer
List of Tables
- Oncomark Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Oncomark Ltd Pipeline Products by Equipment Type
- Oncomark Ltd Pipeline Products by Indication
- Oncomark Ltd, Key Facts
- Oncomark Ltd, Major Products and Services
- Oncomark Ltd Number of Pipeline Products by Development Stage
- Oncomark Ltd Pipeline Products Summary by Development Stage
- OncoMasTR - Bladder Cancer - Product Status
- OncoMasTR - Bladder Cancer - Product Description
- OncoMasTR - Breast Cancer - Product Status
- OncoMasTR - Breast Cancer - Product Description
- OncoMasTR - Colorectal Cancer - Product Status
- OncoMasTR - Colorectal Cancer - Product Description
- OncoMasTR - Melanoma - Product Status
- OncoMasTR - Melanoma - Product Description
- OncoMasTR - Multiple Myeloma - Product Status
- OncoMasTR - Multiple Myeloma - Product Description
- OncoMasTR - Predictive Biomarker Test - Product Status
- OncoMasTR - Predictive Biomarker Test - Product Description
- OncoMasTR - Prostate Cancer - Product Status
- OncoMasTR - Prostate Cancer - Product Description
- Oncomark Ltd, Key Employees
- Glossary
List of Figures
- Oncomark Ltd Pipeline Products by Equipment Type
- Oncomark Ltd Pipeline Products by Development Stage
Companies Mentioned
A selection of companies mentioned in this report includes:
- SISK Healthcare, Ltd.
- Quest Diagnostics Ireland Limited
- ArcRoyal
